Great Lakes Advisors, LLC
- SEC CIK
- 0001078013
- Latest filing
- Aug 10, 2026
SUPN holding history
Supernus Pharmaceuticals, Inc. in every 13F filed by Great Lakes Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SUPN overviewAll 13F holders of SUPNFull Q2 2026 holdings
- Shares (Q2 2026)
- 29,800
- Value
- $1.39M
- % of portfolio
- <0.1%
- Quarters held
- 8
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 29,800 | $1.39M | <0.1% | −18,380−38.1% | Reduced | Holders |
| Q1 2026 | 48,180 | $2.49M | <0.1% | −4,434−8.4% | Reduced | Holders |
| Q4 2025 | 52,614 | $2.61M | <0.1% | −18,617−26.1% | Reduced | Holders |
| Q3 2025 | 71,231 | $3.40M | <0.1% | −70,950−49.9% | Reduced | Holders |
| Q2 2025 | 142,181 | $4.48M | <0.1% | −21,399−13.1% | Reduced | Holders |
| Q1 2025 | 163,580 | $5.36M | <0.1% | −5,977−3.5% | Reduced | Holders |
| Q4 2024 | 169,557 | $6.13M | 0.1% | +169,557 | New | Holders |
| Q4 2021 | 0 | $0 | 0.0% | −8,102−100.0% | Sold out | Holders |
| Q3 2021 | 8,102 | $216.0K | <0.1% | +8,102 | New | Holders |